Processing

Please wait...

Settings

Settings

Goto Application

1. WO1997025051 - ORAL ADMINISTRATION OF EFFECTIVE AMOUNTS OF FORMS OF HYALURONIC ACID

Publication Number WO/1997/025051
Publication Date 17.07.1997
International Application No. PCT/CA1997/000007
International Filing Date 08.01.1997
Chapter 2 Demand Filed 28.07.1997
IPC
A61K 31/728 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
70Carbohydrates; Sugars; Derivatives thereof
715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
726Glycosaminoglycans, i.e. mucopolysaccharides
728Hyaluronic acid
CPC
A61K 31/728
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
70Carbohydrates; Sugars; Derivatives thereof
715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
726Glycosaminoglycans, i.e. mucopolysaccharides
728Hyaluronic acid
A61P 9/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
9Drugs for disorders of the cardiovascular system
A61P 9/10
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
9Drugs for disorders of the cardiovascular system
10for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applicants
  • HYAL PHARMACEUTICAL CORPORATION [CA]/[CA] (AllExceptUS)
  • TURLEY, Eva, Anne [CA]/[CA] (UsOnly)
  • ASCULAI, Samuel, Simon [US]/[CA] (UsOnly)
Inventors
  • TURLEY, Eva, Anne
  • ASCULAI, Samuel, Simon
Agents
  • HUGHES, ETIGSON
Priority Data
2,167,04411.01.1996CA
2,193,92124.12.1996CA
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) ORAL ADMINISTRATION OF EFFECTIVE AMOUNTS OF FORMS OF HYALURONIC ACID
(FR) ADMINISTRATION ORALE DE QUANTITES EFFICACES DE FORMES DE L'ACIDE HYALURONIQUE
Abstract
(EN)
This invention relates to the oral administration of forms of hyaluronic acid (for example hyaluronan (hyaluronic acid) and pharmaceutically acceptable salts thereof such as sodium hyaluronate), and orally administrable dosage forms containing forms of hyaluronic acid, for the prevention and/or treatment of diseases and/or conditions such as the prevention of restenosis and the treatment of an infarct (heart attack) or a stroke. The oral administration and the orally administered dosage forms may also include therapeutic agents and/or medicines which may be administered orally for the treatment and/or prevention of the diseases and/or conditions with the forms of hyaluronic acid (hyaluronan) previously described.
(FR)
L'invention concerne l'administration orale de formes d'acide hyaluronique (par exemple le hyaluronan (acide hyaluronique) et ses sels pharmaceutiquement acceptables, tels l'hyaluronate de sodium), ainsi que des formes posologiques pouvant être administrées par voie orale et contenant des formes d'acide hyaluronique, pour la prévention et/ou le traitement de maladies et/ou d'états pathologiques, par exemple prévention de la resténose et traitement d'un infarctus (attaque cardiaque) ou d'un accident vasculaire cérébral. L'administration orale et les formes posologiques administrées par voie orale peuvent également comprendre des agents thérapeutiques et/ou des médicaments qui peuvent être administrés par voie orale pour le traitement et/ou la prévention des maladies et/ou des états pathologiques par les formes d'acide hyaluronique (hyaluronan) décrites ci-dessus.
Also published as
KR1019980704360
MXPA/a/1998/005588
Latest bibliographic data on file with the International Bureau